SEC Form 4 · accession 0001179110-16-027766
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Q Morris
Officer — Executive VP & CDO
Period of report
Jul 18, 2016
Accepted (ET)
Jul 20, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.05 | Jul 18, 2016 | A | 110,000 | A | Jul 18, 2017 | Jul 18, 2026 | Common stock | 110,000 | 110,000 | D |
Explanation of responses
- F1Exercisable as to 36,667 shares commencing on July 18, 2017, 36,667 shares commencing on July 18, 2018 and 36,666 shares commencing on July 18, 2019.